[Plasma lipoprotein levels and functional status of thrombocytes in patients with ischemic heart disease during treatment with essential phospholipids].
Variations in platelet aggregation activity before and after the control of lipid metabolism with lecithin linoleate (essential preparation, 1800 mg EPL daily) were examined in coronary patients with pronounced hyperlipidemia. A considerable change was noted in the ratios of LP fractions, that is, rising HDLP in the presence of decreasing total plasma lipids, Changes in plasma lipid composition were accompanied with a reduction of platelet aggregation activity that persisted for 3 months following the discontinuation of the drug. Correlation and regression analyses of relationships between platelet aggregation and HDLP levels were carried out.